Aimovig (erenumab-aooe) - Amgen
Ubrelvy (ubrogepant) - AbbVie
Vyepti (eptinezumab-jjmr) - Teva, Lundbeck
Emgality (galcanezumab-gnlm) - Eli Lilly, Daiichi Sankyo
Ajovy (fremanezumab-vfrm) - Teva
Qulipta (atogepant) - AbbVie
Nurtec ODT (rimegepant ODT) - Pfizer
https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.70117
 
Ong, B.1; El Ahdab, J.2; Thompson, N.R.1; Bhagat, M.3; Ney, J.P.4; Weathers, A.2
 
Jun 11, 2026
 
Prev Next